Aflibercept Intervention in Experimental Branch Retinal Vein Occlusion Results in Upregulation of DnaJ Homolog Subfamily C Member 17

Aflibercept is an inhibitor of vascular endothelial growth factor (VEGF) used to treat macular edema following branch retinal vein occlusion (BRVO). Despite well-documented efficacy, there is limited knowledge about proteome changes following aflibercept intervention in BRVO. Proteome changes may pr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Ophthalmol
Autors principals: Cehofski, Lasse Jørgensen, Kruse, Anders, Alsing, Alexander Nørgård, Sejergaard, Benn Falch, Nielsen, Jonas Ellegaard, Pedersen, Shona, Muttuvelu, Danson Vasanthan, Kirkeby, Svend, Honoré, Bent, Vorum, Henrik
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7960061/
https://ncbi.nlm.nih.gov/pubmed/33747556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6690260
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars